Cutaneous and subcutaneous pleomorphic liposarcoma: A clinicopathologic study of 29 cases with evaluation of MDM2 gene amplification in 26

American Journal of Surgical Pathology

Volumn 36, Issue 7, 2012, Pages 1047-1051

  Gardner, Jerad M ^a   Dandekar, Monisha ^b   Thomas, Dafydd ^b   Goldblum, John R ^b   Weiss, Sharon W ^a   Billings, Steven D ^b   Lucas, David R ^b   McHugh, Jonathan B ^b   Patel, Rajiv M ^b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

cutaneous sarcoma; dedifferentiated liposarcoma; liposarcoma; MDM2 gene amplification; pleomorphic liposarcoma

Indexed keywords

PROTEIN MDM2;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CHILD; CLINICAL TRIAL; ENZYMOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; LIPOSARCOMA; MALE; MIDDLE AGED; MITOSIS INDEX; MULTICENTER STUDY; NECROSIS; PATHOLOGY; PHENOTYPE; PRESCHOOL CHILD; PROGNOSIS; SKIN TUMOR; TIME; TUMOR RECURRENCE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; GENE AMPLIFICATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOSARCOMA; MALE; MIDDLE AGED; MITOTIC INDEX; NECROSIS; NEOPLASM RECURRENCE, LOCAL; PHENOTYPE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MDM2; SKIN NEOPLASMS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84863308180     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182517b96     Document Type: Article

References (13)

1. Boland JM, Weiss SW, Oliveira AM, et al. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases. Am J Surg Pathol. 2010;34:837-843.
2. Dei Tos AP, Mentzel T, Fletcher CDM. Primary liposarcoma of the skin: a rare neoplasm with unusual high grade features. Am J Dermatopathol. 1998;20:332.
3. Fletcher CDM, Unni KK, Mertens F. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002;47:44-45.
4. Gebhard S, Coindre JM, Michels JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2002;26: 601-616. (Pubitemid 34438720)
5. Ghadimi MP, Liu P, Peng T, et al. Pleomorphic liposarcoma: clinical observation and molecular variables. Cancer. 2011; 117:5359-5369.
6. Hornick JL, Bosenberg MW, Mentzel T, et al. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am J Surg Pathol. 2004;28:1257-1267. (Pubitemid 39336365)
7. Mariñ o-Enŕquez A, Fletcher CDM, Cin PD, et al. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Am J Surg Pathol. 2010;34:1122-1131.
8. Nilbert M, Mitelman F, Mandahl N, et al. MDM2 gene amplification correlates with ring chromosomes in soft tissue tumors. Genes Chromosomes Cancer. 1994;9:261-265. (Pubitemid 24114830)
9. Schneider-Stock R, Walter H, Radig K, et al. MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas. J Cancer Res Clin Oncol. 1998;124:532-540. (Pubitemid 28513115)
10. Shimada S, Ishizawa T, Ishizawa K, et al. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum Pathol. 2006;37:1123-1129. (Pubitemid 44286984)
11. Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37-42. (Pubitemid 14223231)
12. Val Bernal JF, Gonzá lez Vela MC, Cuevas J. Primary purely intradermal pleomorphic liposarcoma. J Cutan Pathol. 2003;30: 516-520. (Pubitemid 37129902)
13. Weaver J, Downs-Kelly E, Goldblum JR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol. 2008;21:943-949.